杜皮鲁玛
医学
肺病
队列
慢性阻塞性肺病
人口
队列研究
内科学
环境卫生
哮喘
作者
Chuan-Yen Sun,Yohannes Tesfaigzi,Gin-Yi Lee,Yi-Hsuan Chen,Scott T. Weiss,Kevin Sheng-Kai
标识
DOI:10.1016/j.jaci.2024.09.019
摘要
Previous randomized controlled trials had established the efficacy of dupilumab among patients with chronic obstructive pulmonary disease (COPD) treated with triple therapy over 52 weeks of follow-up.
科研通智能强力驱动
Strongly Powered by AbleSci AI